Schedule a Meeting
Get a SampleJanuary 2025
The global medical devices market size is calculated at USD 678.88 billion in 2025 and is expected to reach around USD 1,146.95 billion by 2034, expanding at a CAGR of 6% from 2025 to 2034. The North America medical devices market size reached USD 256.18 billion in 2024 and is expanding at a CAGR of 6.05% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The plastic medical devices market size accounted for USD 640.45 billion in 2024 and is expected to reach around USD 1,146.95 billion by 2034, expanding at a CAGR of 6% from 2025 to 2034.
The U.S. medical devices market size was estimated at USD 180.02 billion in 2024 and is predicted to be worth around USD 328.65 billion by 2034, at a CAGR of 6.2% from 2025 to 2034.
North America held the largest share of the medical device market in 2024. This is mainly due to its well-established healthcare system and advanced healthcare facilities that support the adoption of medical devices. The region is at the forefront of technological advancements, helping the North American medical device industry to develop innovative medical devices. The region is home to many well-known medical device manufacturing companies. Government support and initiatives and favorable reimbursement policies further support the adoption of medical devices.
The U.S. is a major contributor to the North American medical devices market. The U.S. stands as the global leader in medical device production. The rapid shift toward the home healthcare model is boosting the adoption of medical devices. The rising adoption of new and advanced medical technologies for enhancing critical disease diagnosis and treatment procedures is likely to impel the market growth in the region. In addition, the increasing prevalence of chronic conditions and increasing healthcare expenses contribute to regional market growth.
Asia Pacific is emerging as the fastest-growing region due to the rising prevalence of chronic diseases, such as diabetes, cardiovascular diseases (CVDs), and high blood pressure. These diseases often require regular monitoring to manage conditions and reduce fatalities. This, in turn, boosts the demand for monitoring devices, as they allow patients to check vital health parameters at home. With the rising healthcare costs, people are shifting toward home healthcare, boosting the adoption of medical devices.
India and China are expected to lead the Asia Pacific medical devices market. This is mainly due to the growing awareness about health and wellness, rising per capita income, and increasing aging population. As the population ages, the need for medical intervention increases, supporting market growth. Moreover, governments of these countries is investing heavily to advance healthcare infrastructure, contributing to market growth.
Increasing investment in Research & Development (R&D) activity by medical technology companies for the development of new and advanced medical devices and easy approval for those devices by the regulatory authorities expected to impel the market growth fro medical devices over the upcoming years. For instance, according to the U.S. Food and Drug Administration (USFDA) database, there were nearly 54 and 27 new medical devices approved and cleared by the institute in the year 2018 and 2017 respectively. Increasing demand for innovative therapies along with the technological advancements in the medical devices to overcome the unmet requirements in the healthcare sector considered as the prime factor supporting the growth of medical devices during the forthcoming years.
However, data security threat may hamper the market growth for medical devices as internet connection is required for transferring patient’s data from remote devices to the physician. Hence, this increases threat for data security. Rising trend for connected devices makes them attractive and thus increases the risk for data breaches or hacks. For instance, in March 2020, critical patient’s data including medical questionnaires, copies of driving license, passport, and national insurance number were leaked for over 2,300 patients of Hammersmith Medicines Research. The research firm was carrying out trials for COVID-19 vaccine on these patients.
| Report Highlights | Details |
| Market Size in 2024 | USD 640.45 Billion |
| Market Size in 2025 | USD 678.88 Billion |
| Market Size by 2034 | USD 1,146.95 Billion |
| Growth Rate from 2025 to 2034 | CAGR of 6% |
| Largest Market | North America |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | Product, Therapeutic Application, End User, Region |
| Regional Scope | Asia Pacific, North America, Europe, Latin America, Middle East and Africa |
Increasing Adoption of 3D Printing of Medical Devices
Surgical equipment, dental restorations, and orthopedic and cranial implants are among the medical items created via 3D printing. Medical gadgets and implants developed using 3D printing may be more successful than those made using mass production methods since they are made specifically for the physiology of a patient or even for a particular surgery. For instance, surgeons are already using personalized surgery and patient-specific 3D-printed equipment and implants during knee surgery, where they have discovered that they hasten recovery and lower patient pain levels. With 3D printing, there is a significant opportunity to raise product quality in density and orthodontic procedures.
Intricate Regulatory Requirements:
Increased expenditures for new product development and patient service offerings are anticipated to result from regulatory reforms. The General Data Protection Regulation, which was implemented by the European Union, as well as adjustments to the device approvals, are a few of these developments connected to consumption confidentiality. The US FDA has prolonged the time period to complete the marketing authorization by 55% during the past decade by requesting additional clinical data to back up the security and effectiveness claims of medical equipment like endoscopic instruments. Investments in novel devices are strained by the possibility of lost sales as a result of device release delays and increased expenses as a result of demanding regulatory procedures, which has an impact on the expansion of the market for medical devices.
Technological Transformation in the Devices by the Companies
The majority of medical device companies are undergoing a significant technological shift that will ultimately transform them into MedTech entities. Manufacturers are using data to incorporate intelligence into their products in an effort to be closer to the end user, and it is swiftly evolving into a crucial component of the new device value proposition. Organizations are also participating in unconventional alliances. Future advancements in artificial intelligence will simplify the management of chronic diseases from the perspective of the patient. Technology will also have a significant impact on the prevention of treatment, cutting down on the amount of time spent in hospitals. For instance, industrial firms are increasingly concentrating on robotic surgery.
The cardiovascular devices segment dominated the medical devices market in 2024. Since heart diseases remains one of the leading causes of death worldwide, they require regular monitoring to manage conditions. Cardiac monitoring devices have proven to be effective in monitoring cardiac health. The prevalence of cardiovascular disease (CVDs) has increased significantly due to factors such as lifestyle changes, stress, and unhealthy eating habits, boosting the demand for cardiovascular devices for diagnostics as well as surgical purposes. In addition, the advent of modern devices, such as wearable ECG monitors, smartwatches, and advanced Holter monitors equipped with sensors to detect abnormalities in heart rhythm and other vital signs, contribute to segmental dominance.
The diagnostic imaging segment is expected to expand at a significant growth rate in the coming years. The increasing awareness about early disease detection is a major factor boosting the demand for diagnostic devices. The rising prevalence of chronic diseases further supports segmental growth, as these diseases require timely diagnosis. Rising advancements in imaging technologies further improve the accuracy of diagnostic imaging, enhancing patient outcomes.
The diabetes care segment is projected to grow at a notable rate during the forecast period. The segmental growth is attributed to the rising prevalence of diabetes worldwide. According to the WHO, approximately 830 million people worldwide have diabetes. More than half of people living with diabetes are not receiving treatment. Diabetes care devices, such as continuous glucose monitoring, emerged as a promising approach to managing diabetes. In addition, the rising awareness about the adverse impact of untreated diabetes contributes to segmental growth.
The hospitals & ambulatory surgery centers (ASCs) segment dominated the medical devices market in 2024. This is mainly due to increased patient pool and admission rates in these settings. Hospitals and ASCs are considered primary care centers. Moreover, these settings are often equipped with advanced medical devices, such as monitoring, diagnostics, and surgical devices, appealing to a broader patient base to perform procedures. The increasing shift toward outpatient settings, such as ASCs, further contributes to market expansion.
The clinics segment is likely to grow at a considerable rate over the studied period. The rising demand for personalized care is a major factor driving the growth of the segment. Clinics focus on patient-centric care approaches that enhance patient care. Furthermore, the availability of skilled healthcare professionals encourages people to receive care from these settings.
The global medical devices market is highly fragmented owing to the presence of large number of market players on global as well as regional level. Among these companies, Medtronic capture the largest market share with diverse product portfolio and strong brand name in the global market. Apart from this, most of the industry players invest prominently in the Research & Development (R&D) activity to develop new products and upgrade the existing product list. Furthermore, these market players largely focus on expanding their distributors across the globe that allows companies to expand their product offerings.
By Type
By End-user
By Geography
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
January 2025
March 2025
August 2024
January 2025